Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events

Marianne Davies,1–3 Emily A Duffield3 1Yale School of Nursing, 2Department of Medical Oncology, Yale Comprehensive Cancer Center, 3Department of Nursing, Smilow Cancer Hospital at Yale-New Haven Hospital, New Haven, CT, USA Abstract: Immune checkpoint inhibitors (ICPIs), in the form of mo...

Полное описание

Библиографические подробности

Главные авторы:	Davies M, Duffield EA
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2017-08-01
Серии:	ImmunoTargets and Therapy
Предметы:	immune-mediated adverse event checkpoint inhibitor immunotherapy CTLA-4 PD-1 PD-L1
Online-ссылка:	https://www.dovepress.com/safety-of-checkpoint-inhibitors-for-cancer-treatment-strategies-for-pa-peer-reviewed-article-ITT
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!